Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 366 entries
Sorted by: Best Match Show Resources per page
Educational interventions in kidney disease care: a systematic review of randomized trials

Educational trials

Khunti K.
GSID: YcUGXIUUjhEJ
JO Mason, K Khunti, M Stone, A Farooqi… - American Journal of Kidney …, 2008 - Elsevier

… educational interventions aimed at empowering patients are successful in chronic disease management. Our aim was to conduct a systematic review of the effectiveness of such educational … this group has additional educational needs that are beyond the scope...

Cite
Mason, J. O., Khunti, K., Stone, M., Farooqi, A., & Carr, S. (2008). Educational interventions in kidney disease care: a systematic review of randomized trials. American Journal of Kidney Diseases, 51(6), 933-951.
Mason, J. O., et al. "Educational interventions in kidney disease care: a systematic review of randomized trials." American Journal of Kidney Diseases 51.6 (2008): 933-951.
Copy Download .nbib Format: MLA
The adsorption of Cu on the CeO.

Physical chemistry chemical physics : PCCP

Chutia A, Gibson EK, Farrow MR, Wells PP, Scanlon DO, Dimitratos N, Willock DJ, Catlow CRA.
PMID: 28926035
Phys Chem Chem Phys. 2017 Oct 18;19(40):27191-27203. doi: 10.1039/c7cp04144f.

We report a detailed density functional theory (DFT) study in conjunction with extended X-ray absorption fine structure (EXAFS) experiments on the geometrical and local electronic properties of Cu adatoms and Cu(ii) ions in presence of water molecules and of...

Cite
Chutia A, Gibson EK, Farrow MR, et al. The adsorption of Cu on the CeO. Phys Chem Chem Phys. 2017;19(40):27191-27203doi: 10.1039/c7cp04144f.
Chutia, A., Gibson, E. K., Farrow, M. R., Wells, P. P., Scanlon, D. O., Dimitratos, N., Willock, D. J., & Catlow, C. R. A. (2017). The adsorption of Cu on the CeO. Physical chemistry chemical physics : PCCP, 19(40), 27191-27203. https://doi.org/10.1039/c7cp04144f
Chutia, Arunabhiram, et al. "The adsorption of Cu on the CeO." Physical chemistry chemical physics : PCCP vol. 19,40 (2017): 27191-27203. doi: https://doi.org/10.1039/c7cp04144f
Chutia A, Gibson EK, Farrow MR, Wells PP, Scanlon DO, Dimitratos N, Willock DJ, Catlow CRA. The adsorption of Cu on the CeO. Phys Chem Chem Phys. 2017 Oct 18;19(40):27191-27203. doi: 10.1039/c7cp04144f. PMID: 28926035.
Copy Download .nbib Format: NLM
Health economic evaluation of type 2 diabetes mellitus: a clinical practice focused review.

Clinical medicine insights. Endocrinology and diabetes

Liebl A, Khunti K, Orozco-Beltran D, Yale JF.
PMID: 25861233
Clin Med Insights Endocrinol Diabetes. 2015 Mar 24;8:13-9. doi: 10.4137/CMED.S20906. eCollection 2015.

Type 2 diabetes mellitus (T2D) is a growing healthcare burden primarily due to long-term complications. Strict glycemic control helps in preventing complications, and early introduction of insulin may be more cost-effective than maintaining patients on multiple oral agents. This...

Cite
Liebl A, Khunti K, Orozco-Beltran D, et al. Health economic evaluation of type 2 diabetes mellitus: a clinical practice focused review. Clin Med Insights Endocrinol Diabetes. 2015;8:13-9doi: 10.4137/CMED.S20906.
Liebl, A., Khunti, K., Orozco-Beltran, D., & Yale, J. F. (2015). Health economic evaluation of type 2 diabetes mellitus: a clinical practice focused review. Clinical medicine insights. Endocrinology and diabetes, 813-9. https://doi.org/10.4137/CMED.S20906
Liebl, Andreas, et al. "Health economic evaluation of type 2 diabetes mellitus: a clinical practice focused review." Clinical medicine insights. Endocrinology and diabetes vol. 8 (2015): 13-9. doi: https://doi.org/10.4137/CMED.S20906
Liebl A, Khunti K, Orozco-Beltran D, Yale JF. Health economic evaluation of type 2 diabetes mellitus: a clinical practice focused review. Clin Med Insights Endocrinol Diabetes. 2015 Mar 24;8:13-9. doi: 10.4137/CMED.S20906. eCollection 2015. PMID: 25861233; PMCID: PMC4374638.
Copy Download .nbib Format: NLM
Absence of low energy magnetic spin-fluctuations in isovalently and aliovalently doped LaCo2B2 superconducting compounds.

Journal of physics. Condensed matter : an Institute of Physics journal

Majumder M, Ghoshray A, Khuntia P, Mazumdar C, Poddar A, Baenitz M, Ghoshray K.
PMID: 27355521
J Phys Condens Matter. 2016 Sep 01;28(34):345701. doi: 10.1088/0953-8984/28/34/345701. Epub 2016 Jun 29.

Magnetization, resistivity and (11)B, (59)Co NMR measurements have been performed on the Pauli paramagnet [Formula: see text], and the superconductors [Formula: see text] ([Formula: see text] K) and [Formula: see text] ([Formula: see text] K). The site selective NMR...

Cite
Majumder M, Ghoshray A, Khuntia P, et al. Absence of low energy magnetic spin-fluctuations in isovalently and aliovalently doped LaCo2B2 superconducting compounds. J Phys Condens Matter. 2016;28(34):345701doi: 10.1088/0953-8984/28/34/345701.
Majumder, M., Ghoshray, A., Khuntia, P., Mazumdar, C., Poddar, A., Baenitz, M., & Ghoshray, K. (2016). Absence of low energy magnetic spin-fluctuations in isovalently and aliovalently doped LaCo2B2 superconducting compounds. Journal of physics. Condensed matter : an Institute of Physics journal, 28(34), 345701. https://doi.org/10.1088/0953-8984/28/34/345701
Majumder, M, et al. "Absence of low energy magnetic spin-fluctuations in isovalently and aliovalently doped LaCo2B2 superconducting compounds." Journal of physics. Condensed matter : an Institute of Physics journal vol. 28,34 (2016): 345701. doi: https://doi.org/10.1088/0953-8984/28/34/345701
Majumder M, Ghoshray A, Khuntia P, Mazumdar C, Poddar A, Baenitz M, Ghoshray K. Absence of low energy magnetic spin-fluctuations in isovalently and aliovalently doped LaCo2B2 superconducting compounds. J Phys Condens Matter. 2016 Sep 01;28(34):345701. doi: 10.1088/0953-8984/28/34/345701. Epub 2016 Jun 29. PMID: 27355521.
Copy Download .nbib Format: NLM
Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Khunti K, Mohan V, Jain SM, Boesgaard TW, Begtrup K, Sethi B.
PMID: 28332144
Diabetes Ther. 2017 Jun;8(3):673-682. doi: 10.1007/s13300-017-0252-9. Epub 2017 Mar 22.

INTRODUCTION: The efficacy and safety of insulin degludec/liraglutide (IDegLira) has been evaluated in the Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes (DUAL) phase 3 clinical trial program. In this post hoc analysis, we compared the...

Cite
Khunti K, Mohan V, Jain SM, et al. Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program. Diabetes Ther. 2017;8(3):673-682doi: 10.1007/s13300-017-0252-9.
Khunti, K., Mohan, V., Jain, S. M., Boesgaard, T. W., Begtrup, K., & Sethi, B. (2017). Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(3), 673-682. https://doi.org/10.1007/s13300-017-0252-9
Khunti, Kamlesh, et al. "Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,3 (2017): 673-682. doi: https://doi.org/10.1007/s13300-017-0252-9
Khunti K, Mohan V, Jain SM, Boesgaard TW, Begtrup K, Sethi B. Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program. Diabetes Ther. 2017 Jun;8(3):673-682. doi: 10.1007/s13300-017-0252-9. Epub 2017 Mar 22. PMID: 28332144; PMCID: PMC5446379.
Copy Download .nbib Format: NLM
Systematic review of the development, implementation and availability of smart-phone applications for assessing type 2 diabetes risk.

Diabetic medicine : a journal of the British Diabetic Association

Gray LJ, Leigh T, Davies MJ, Patel N, Stone M, Bonar M, Badge R, Khunti K.
PMID: 23683104
Diabet Med. 2013 Jun;30(6):758-60. doi: 10.1111/dme.12115.

No abstract available.

Cite
Gray LJ, Leigh T, Davies MJ, et al. Systematic review of the development, implementation and availability of smart-phone applications for assessing type 2 diabetes risk. Diabet Med. 2013;30(6):758-60doi: 10.1111/dme.12115.
Gray, L. J., Leigh, T., Davies, M. J., Patel, N., Stone, M., Bonar, M., Badge, R., & Khunti, K. (2013). Systematic review of the development, implementation and availability of smart-phone applications for assessing type 2 diabetes risk. Diabetic medicine : a journal of the British Diabetic Association, 30(6), 758-60. https://doi.org/10.1111/dme.12115
Gray, L J, et al. "Systematic review of the development, implementation and availability of smart-phone applications for assessing type 2 diabetes risk." Diabetic medicine : a journal of the British Diabetic Association vol. 30,6 (2013): 758-60. doi: https://doi.org/10.1111/dme.12115
Gray LJ, Leigh T, Davies MJ, Patel N, Stone M, Bonar M, Badge R, Khunti K. Systematic review of the development, implementation and availability of smart-phone applications for assessing type 2 diabetes risk. Diabet Med. 2013 Jun;30(6):758-60. doi: 10.1111/dme.12115. PMID: 23683104.
Copy Download .nbib Format: NLM
Reaction of N-heterocyclic carbenes with chalcones leading to the synthesis of deoxy-Breslow intermediates in their oxidized form.

Chemical communications (Cambridge, England)

Bhunia A, Thorat S, Gonnade RG, Biju AT.
PMID: 26226931
Chem Commun (Camb). 2015 Sep 14;51(71):13690-3. doi: 10.1039/c5cc05800g.

The synthesis of deoxy-Breslow intermediates in their oxidized form has been developed via the reaction of N-heterocyclic carbenes (NHCs) with chalcones. Moreover, the initial tetrahedral adduct formed from the 1,4-addition of NHCs to chalcones is also isolated.

Cite
Bhunia A, Thorat S, Gonnade RG, et al. Reaction of N-heterocyclic carbenes with chalcones leading to the synthesis of deoxy-Breslow intermediates in their oxidized form. Chem Commun (Camb). 2015;51(71):13690-3doi: 10.1039/c5cc05800g.
Bhunia, A., Thorat, S., Gonnade, R. G., & Biju, A. T. (2015). Reaction of N-heterocyclic carbenes with chalcones leading to the synthesis of deoxy-Breslow intermediates in their oxidized form. Chemical communications (Cambridge, England), 51(71), 13690-3. https://doi.org/10.1039/c5cc05800g
Bhunia, Anup, et al. "Reaction of N-heterocyclic carbenes with chalcones leading to the synthesis of deoxy-Breslow intermediates in their oxidized form." Chemical communications (Cambridge, England) vol. 51,71 (2015): 13690-3. doi: https://doi.org/10.1039/c5cc05800g
Bhunia A, Thorat S, Gonnade RG, Biju AT. Reaction of N-heterocyclic carbenes with chalcones leading to the synthesis of deoxy-Breslow intermediates in their oxidized form. Chem Commun (Camb). 2015 Sep 14;51(71):13690-3. doi: 10.1039/c5cc05800g. PMID: 26226931.
Copy Download .nbib Format: NLM
Giant Zn14 molecular building block in hydrogen-bonded network with permanent porosity for gas uptake.

Journal of the American Chemical Society

Mondal SS, Bhunia A, Kelling A, Schilde U, Janiak C, Holdt HJ.
PMID: 24313724
J Am Chem Soc. 2014 Jan 08;136(1):44-7. doi: 10.1021/ja410595q. Epub 2013 Dec 16.

In situ imidazolate-4,5-diamide-2-olate linker generation leads to the formation of a [Zn14(L2)12(O)(OH)2(H2O)4] molecular building block (MBB) with a Zn6 octahedron inscribed in a Zn8 cube. The MBBs connect by amide-amide hydrogen bonds to a 3D robust supramolecular network which...

Cite
Mondal SS, Bhunia A, Kelling A, et al. Giant Zn14 molecular building block in hydrogen-bonded network with permanent porosity for gas uptake. J Am Chem Soc. 2013;136(1):44-7doi: 10.1021/ja410595q.
Mondal, S. S., Bhunia, A., Kelling, A., Schilde, U., Janiak, C., & Holdt, H. J. (2014). Giant Zn14 molecular building block in hydrogen-bonded network with permanent porosity for gas uptake. Journal of the American Chemical Society, 136(1), 44-7. https://doi.org/10.1021/ja410595q
Mondal, Suvendu Sekhar, et al. "Giant Zn14 molecular building block in hydrogen-bonded network with permanent porosity for gas uptake." Journal of the American Chemical Society vol. 136,1 (2014): 44-7. doi: https://doi.org/10.1021/ja410595q
Mondal SS, Bhunia A, Kelling A, Schilde U, Janiak C, Holdt HJ. Giant Zn14 molecular building block in hydrogen-bonded network with permanent porosity for gas uptake. J Am Chem Soc. 2014 Jan 08;136(1):44-7. doi: 10.1021/ja410595q. Epub 2013 Dec 16. PMID: 24313724.
Copy Download .nbib Format: NLM
The National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Leicestershire, Northamptonshire and Rutland (LNR): a programme protocol.

Implementation science : IS

Baker R, Robertson N, Rogers S, Davies M, Brunskill N, Khunti K, Steiner M, Williams M, Sinfield P.
PMID: 19906317
Implement Sci. 2009 Nov 12;4:72. doi: 10.1186/1748-5908-4-72.

BACKGROUND: In October 2008, the National Institute for Health Research launched nine new research projects to develop and investigate methods of translating research evidence into practice. Given the title Collaborations for Leadership in Applied Health Research and Care (CLAHRC),...

Cite
Baker R, Robertson N, Rogers S, et al. The National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Leicestershire, Northamptonshire and Rutland (LNR): a programme protocol. Implement Sci. 2009;4:72doi: 10.1186/1748-5908-4-72.
Baker, R., Robertson, N., Rogers, S., Davies, M., Brunskill, N., Khunti, K., Steiner, M., Williams, M., & Sinfield, P. (2009). The National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Leicestershire, Northamptonshire and Rutland (LNR): a programme protocol. Implementation science : IS, 472. https://doi.org/10.1186/1748-5908-4-72
Baker, Richard, et al. "The National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Leicestershire, Northamptonshire and Rutland (LNR): a programme protocol." Implementation science : IS vol. 4 (2009): 72. doi: https://doi.org/10.1186/1748-5908-4-72
Baker R, Robertson N, Rogers S, Davies M, Brunskill N, Khunti K, Steiner M, Williams M, Sinfield P. The National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Leicestershire, Northamptonshire and Rutland (LNR): a programme protocol. Implement Sci. 2009 Nov 12;4:72. doi: 10.1186/1748-5908-4-72. PMID: 19906317; PMCID: PMC2780974.
Copy Download .nbib Format: NLM
Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus.

BMC medicine

Nisal K, Kela R, Khunti K, Davies MJ.
PMID: 23198896
BMC Med. 2012 Nov 30;10:152. doi: 10.1186/1741-7015-10-152.

Type 2 diabetes mellitus is widely prevalent and is often coexistent with obesity. Many of the available treatment options have side effects such as weight gain which often affect patient's willingness to continue the treatment. Effective weight loss, lack...

Cite
Nisal K, Kela R, Khunti K, et al. Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus. BMC Med. 2012;10:152doi: 10.1186/1741-7015-10-152.
Nisal, K., Kela, R., Khunti, K., & Davies, M. J. (2012). Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus. BMC medicine, 10152. https://doi.org/10.1186/1741-7015-10-152
Nisal, Kaustubh, et al. "Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus." BMC medicine vol. 10 (2012): 152. doi: https://doi.org/10.1186/1741-7015-10-152
Nisal K, Kela R, Khunti K, Davies MJ. Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus. BMC Med. 2012 Nov 30;10:152. doi: 10.1186/1741-7015-10-152. PMID: 23198896; PMCID: PMC3599222.
Copy Download .nbib Format: NLM
Gate effects in a hexagonal zinc-imidazolate-4-amide-5-imidate framework with flexible methoxy substituents and CO2 selectivity.

Chemical communications (Cambridge, England)

Mondal SS, Bhunia A, Baburin IA, Jäger C, Kelling A, Schilde U, Seifert G, Janiak C, Holdt HJ.
PMID: 23877443
Chem Commun (Camb). 2013 Sep 07;49(69):7599-601. doi: 10.1039/c3cc42156b. Epub 2013 Jul 22.

A new imidazolate-4-amide-5-imidate based MOF, IFP-7, is generated, having flexible methoxy groups, which act as molecular gates for guest molecules. This allows highly selective CO2 sorption over N2 and CH4 gases.

Cite
Mondal SS, Bhunia A, Baburin IA, et al. Gate effects in a hexagonal zinc-imidazolate-4-amide-5-imidate framework with flexible methoxy substituents and CO2 selectivity. Chem Commun (Camb). 2013;49(69):7599-601doi: 10.1039/c3cc42156b.
Mondal, S. S., Bhunia, A., Baburin, I. A., Jäger, C., Kelling, A., Schilde, U., Seifert, G., Janiak, C., & Holdt, H. J. (2013). Gate effects in a hexagonal zinc-imidazolate-4-amide-5-imidate framework with flexible methoxy substituents and CO2 selectivity. Chemical communications (Cambridge, England), 49(69), 7599-601. https://doi.org/10.1039/c3cc42156b
Mondal, Suvendu Sekhar, et al. "Gate effects in a hexagonal zinc-imidazolate-4-amide-5-imidate framework with flexible methoxy substituents and CO2 selectivity." Chemical communications (Cambridge, England) vol. 49,69 (2013): 7599-601. doi: https://doi.org/10.1039/c3cc42156b
Mondal SS, Bhunia A, Baburin IA, Jäger C, Kelling A, Schilde U, Seifert G, Janiak C, Holdt HJ. Gate effects in a hexagonal zinc-imidazolate-4-amide-5-imidate framework with flexible methoxy substituents and CO2 selectivity. Chem Commun (Camb). 2013 Sep 07;49(69):7599-601. doi: 10.1039/c3cc42156b. Epub 2013 Jul 22. PMID: 23877443.
Copy Download .nbib Format: NLM
A review of exenatide: optimizing glycemic control and associated cardiovascular risk factors in type 2 diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Htike ZZ, Khunti K, Davies M.
PMID: 22422427
Diabetes Ther. 2012 Nov;3(1):1-16. doi: 10.1007/s13300-012-0003-x. Epub 2012 Mar 16.

Type 2 diabetes mellitus (T2DM) is a well-recognized risk factor for the development of cardiovascular disease. With an increasing prevalence of obesity, this risk has increased further. Management of T2DM in obese patients is particularly challenging as treatment with...

Cite
Htike ZZ, Khunti K, Davies M. A review of exenatide: optimizing glycemic control and associated cardiovascular risk factors in type 2 diabetes. Diabetes Ther. 2012;3(1):1-16doi: 10.1007/s13300-012-0003-x.
Htike, Z. Z., Khunti, K., & Davies, M. (2012). A review of exenatide: optimizing glycemic control and associated cardiovascular risk factors in type 2 diabetes. Diabetes therapy : research, treatment and education of diabetes and related disorders, 3(1), 1-16. https://doi.org/10.1007/s13300-012-0003-x
Htike, Zin Z, et al. "A review of exenatide: optimizing glycemic control and associated cardiovascular risk factors in type 2 diabetes." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 3,1 (2012): 1-16. doi: https://doi.org/10.1007/s13300-012-0003-x
Htike ZZ, Khunti K, Davies M. A review of exenatide: optimizing glycemic control and associated cardiovascular risk factors in type 2 diabetes. Diabetes Ther. 2012 Nov;3(1):1-16. doi: 10.1007/s13300-012-0003-x. Epub 2012 Mar 16. PMID: 22422427; PMCID: PMC3508112.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 366 entries